![]() |
|
|
RV Bhat, AJ Cole and JM Baraban
Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Transcription regulatory factors are rapidly induced in brain by a wide variety of stimuli and may be important in coordinating changes in gene expression underlying neuronal plasticity. In addition to the transient activation profile typically displayed by many of these genes, zif268 exhibits prominent basal expression in the brain that is dependent on synaptic activity. Accordingly, zif268 may play a key role in regulating neuronal gene expression induced by naturally occurring stimuli. Acute cocaine administration (15 mg/kg i.p.) produces a robust and transient induction of several transcription factors in the brain, including zif268. In the present study we report that, in contrast to the acute effects of a single dose, chronic cocaine treatment (15 mg/kg i.p., twice daily for a total of 10 injections), produces a widespread suppression of basal zif268 mRNA levels in rat forebrain between 8 and 24 hr after the last cocaine injection. This reduction is not evident after a single injection of cocaine or comparable chronic treatment with a structural analog, procaine, that does not share cocaine's uptake inhibitor properties. The suppression of basal zif268 expression may provide a mechanism for producing widespread effects of chronic cocaine administration on neuronal gene expression.
This article has been cited by other articles:
![]() |
F. Fumagalli, F. Bedogni, A. Frasca, L. Di Pasquale, G. Racagni, and M. A. Riva Corticostriatal Up-Regulation of Activity-Regulated Cytoskeletal-Associated Protein Expression after Repeated Exposure to Cocaine Mol. Pharmacol., November 1, 2006; 70(5): 1726 - 1734. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Valjent, B. Aubier, A.-G. Corbille, K. Brami-Cherrier, J. Caboche, P. Topilko, J.-A. Girault, and D. Herve Plasticity-associated gene Krox24/Zif268 is required for long-lasting behavioral effects of cocaine. J. Neurosci., May 3, 2006; 26(18): 4956 - 4960. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Torres and J. M. Horowitz Drugs of Abuse and Brain Gene Expression Psychosom Med, September 1, 1999; 61(5): 630 - 650. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. O'Donovan and J. M. Baraban Major Egr3 Isoforms Are Generated via Alternate Translation Start Sites and Differ in Their Abilities To Activate Transcription Mol. Cell. Biol., July 1, 1999; 19(7): 4711 - 4718. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. B. Fredholm, K. Battig, J. Holmen, A. Nehlig, and E. E. Zvartau Actions of Caffeine in the Brain with Special Reference to Factors That Contribute to Its Widespread Use Pharmacol. Rev., March 1, 1999; 51(1): 83 - 133. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Schiller, R. E. Mains, and B. A. Eipper A Novel Neuroendocrine Intracellular Signaling Pathway Mol. Endocrinol., November 1, 1997; 11(12): 1846 - 1857. [Abstract] [Full Text] |
||||
![]() |
D. N. Darlington, M. R. Schiller, R. E. Mains, and B. A. Eipper Expression of RESP18 in Peptidergic and Catecholaminergic Neurons J. Histochem. Cytochem., September 1, 1997; 45(9): 1265 - 1278. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Ebert and D. L. Wong Differential Activation of the Rat Phenylethanolamine N-Methyltransferase Gene by Sp1 and Egr-1 J. Biol. Chem., July 21, 1995; 270(29): 17299 - 17305. [Abstract] [Full Text] [PDF] |
||||